Take Solutions Limited announces strategic entry into longevity market under Reg 30
Take Solutions Limited has formally announced its strategic expansion into India's longevity and anti-aging market through a Regulation 30 filing. The company plans to leverage its healthcare expertise to develop science-backed nutraceuticals, biohacking solutions, and digital health tools, targeting a global market valued at USD 27.61 billion in 2025 and projected to reach USD 67.03 billion by 2035.

*this image is generated using AI for illustrative purposes only.
Take Solutions Limited has announced its strategic entry into India's longevity and anti-aging market through a comprehensive Regulation 30 filing dated April 17, 2026, marking a significant expansion into the healthcare and wellness sector.
Regulatory Filing Details
The company submitted formal notifications to both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing outlined plans to disrupt the Indian longevity and anti-aging solutions market through science-backed nutraceuticals, biohacking solutions, and technology-enabled preventive healthcare offerings.
| Parameter: | Details |
|---|---|
| Filing Date: | April 17, 2026 |
| BSE Script Code: | 532890 |
| NSE Scrip: | TAKE |
| Regulation: | SEBI Reg 30 (LODR) 2015 |
| Focus Areas: | Nutraceuticals, Biohacking, Digital Health |
Market Opportunity and Growth Projections
The global longevity market presents substantial growth opportunities across multiple segments. The company aims to capitalize on India's growing health-conscious consumer base through its established expertise in clinical research and regulatory processes.
| Market Segment: | 2025 Value | Future Projection | CAGR |
|---|---|---|---|
| Global Longevity Market: | USD 27.61 billion | USD 67.03 billion (2035) | 9.41% |
| India Anti-aging Supplements: | USD 168.60 million | USD 341.40 million (2033) | 9.50% |
| India Anti-aging Services: | USD 567.50 million (2024) | USD 1,059.60 million (2035) | 5.80% |
| India Preventive Healthcare: | USD 197.00 billion | - | - |
Strategic Business Model and Technology Integration
Take Solutions' entry strategy centers on a dual model combining product innovation with technology-enabled health solutions. The company plans to develop science-backed nutraceuticals, biohacking-focused products, and predictive digital tools for tracking metabolic health, sleep, cognition, and biological aging.
"Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible," said Mr. Parmeshvar Dhangare, Director of Take Solutions Limited.
Competitive Positioning and Market Strategy
The company believes its existing capabilities in healthcare operations, regulatory support, and life sciences can be extended to accelerate development, validation, and commercialization in the longevity market. This approach aims to create differentiated offerings in an underpenetrated market with strong repeat-purchase potential and attractive margin profiles, supported by rising consumer awareness and increasing lifestyle disease burden in India.
Historical Stock Returns for Take Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.97% | -22.56% | -22.88% | +46.22% | +339.04% | -41.43% |
How will Take Solutions differentiate its longevity products from established players like Himalaya and Patanjali in India's competitive nutraceuticals market?
What regulatory hurdles might the company face when launching biohacking solutions in India, given the evolving FSSAI guidelines for health supplements?
Could this strategic pivot impact Take Solutions' existing clinical research and IT services business, and how will resources be allocated between segments?


































